Compare Freshworks Inc (FRSH) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs Twist Bioscience Corp — how do they compare? Freshworks Inc trades at $13.92 (market cap $3.56B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 2.8× Freshworks Inc's market cap, and Freshworks Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Freshworks Inc for 39 Days and Twist Bioscience Corp for 27 Days on average.
| FRSH | TWST | |
|---|---|---|
Market Cap | $3.56B | $10.08B |
Volume | 9,066,454 | 4,229,037 |
Sector | Technology | Health |
52-Week High | $13.92 | $205.00 |
52-Week Low | $6.88 | $25.45 |
Typical Hold Time | 39 Days | 27 Days |
Enterprise Value | $2.93B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $13.64, up 0.29% with strong technical momentum showing bullish moving average signals. The company achieved its first GAAP profitability in Q2 2026 with revenue growth of 16% year-over-year, beating earnings expectations. Recent developments include FedRAMP certification progress and leadership in Gartner's ITSM Magic Quadrant, positioning the company for enterprise growth.
FRSH presents a compelling investment case with attractive valuation metrics (P/E 21.63, P/S 4.28) and strong profitability margins (84.96% gross margin, 20.49% net margin). However, elevated EV/EBITDA (43.89) and competitive SaaS market pressures require monitoring. Analyst consensus is evenly split between Buy and Hold with $14.60 price target suggesting modest upside potential from current levels.
TWST trades at $152.05, down 2.31% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported Q2 2026 EPS of -$0.56, missing expectations, continuing a trend of losses despite revenue growth to $376.57M in 2025. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, driving investor optimism.
Outlook remains speculative with high valuation multiples (P/S 21.5, P/B 22.62) and persistent losses, but analyst consensus is bullish (73% buy ratings) with a $145.20 price target. Key risks include cash burn, competitive pressures, and reliance on AI-driven growth catalysts for profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
